To rally the San Diego region in the fight against cancer, the University of California San Diego’s Moores Cancer Center will host its annual SPARK Gala on Saturday, April 16 at the Fairmont Grand Del Mar. The evening will include a three-course dinner with wine pairings, a live luxury auction and dancing. All proceeds will benefit Moores Cancer Center at UC San Diego Health.
Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
Writing in the April 11 issue of The Journal of Clinical Investigation, researchers at University of California, San Diego School of Medicine say abnormalities in a protein that helps transport and sort materials inside cells are linked to axonal dysfunction and degeneration of neurons in Alzheimer’s disease (AD) and Down syndrome (DS).
The University of California, San Diego has received an Andrew W. Mellon Foundation New Directions Fellowship grant—an award intended to assist humanities scholars in acquiring systematic training outside their areas of special interest—for the first time. The $209,000 grant will support Department of History Professor Mark Hendrickson’s efforts to explore how the work of American mining engineers and geologists working abroad between 1880 and 1930 helped shape the development of 20th-century American capitalism, science and foreign policy.
Researchers at the University of California, San Diego School of Medicine have developed a novel method for assessing mortality risk in elderly patients with cancer who also suffer from other serious diseases or conditions. The prognostic model, they say, is more precise and provides a more useful tool for determining the best treatments when more than one disease is involved.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
